
News|Podcasts|April 8, 2024
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Listen
0:00 / 0:00
Christopher Bunick, MD, PhD, delves into current data and guidelines to consider when creating custom treatment plans for patients with atopic dermatitis.
Advertisement
Christopher Bunick, MD, PhD, associate professor of dermatology at Yale School of Medicine in New Haven, Connecticut and Dermatology Times Editorial Advisory Board Member, decodes new atopic dermatitis treatment data and how that translates to personalized options for patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Ritlecitinib Meets Co-Primary End Points in Phase 3 Nonsegmental Vitiligo Trials
2
Evidence-Based Best Practices for Melasma Care
3
RAD 2026: Experts Weigh In on AD Pipeline, Pediatric Care, and Personalized Treatment
4
Earlier JAK Inhibitor Intervention May Improve Alopecia Areata Outcomes
5










